期刊
JOURNAL OF CLINICAL INVESTIGATION
卷 120, 期 12, 页码 4436-4444出版社
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI43786
关键词
-
资金
- NIH [HL64353, HL53949, HL083950, AI024674, U19 AI077439, U19 AI056388]
- NIH Ruth L Kirschstein
- National Research Service Award [HL095314]
- American Lung Association of California
- BBSRC [BB/G001103/1] Funding Source: UKRI
- Biotechnology and Biological Sciences Research Council [BB/G001103/1] Funding Source: researchfish
Th17 cells promote a variety of autoimmune diseases, including psoriasis, multiple sclerosis, rheumatoid arthritis, and inflammatory bowel disease. TGF-beta is required for conversion of naive T cells to Th17 cells, but the mechanisms regulating this process are unknown. Integrin alpha v beta 8 on DCs can activate TGF-beta, and this process contributes to the development of induced Tregs. Here, we have now shown that integrin alpha v beta 8 expression on DCs plays a critical role in the differentiation of Th17 cells. Th17 cells were nearly absent in the colons of mice lacking alpha v beta 8 expression on DCs. In addition, these mice and the DCs harvested from them had an impaired ability to convert naive T cells into Th17 cells in vivo and in vitro, respectively. Importantly, mice lacking alpha v beta 8 on DCs showed near-complete protection from experimental autoimmune encephalomyelitis. Our results therefore suggest that the integrin alpha v beta 8 pathway is biologically important and that alpha v beta 8 expression on DCs could be a therapeutic target for the treatment of Th17-driven autoimmune disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据